These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8920806)

  • 1. Cefuroxime resistance in Escherichia coli. Resistance mechanisms and prevalence.
    Schumacher H; Skibsted U; Skov R; Scheibel J
    APMIS; 1996; 104(7-8):531-8. PubMed ID: 8920806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefuroxime resistance in Klebsiella pneumoniae. Susceptibility to cefotaxime and ceftazidime despite production of ESBLs.
    Schumacher H; Skibsted U; Hansen DS; Scheibel J
    APMIS; 1997 Sep; 105(9):708-16. PubMed ID: 9350215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime.
    Schumacher H; Scheibel J; Moller JK
    J Antimicrob Chemother; 2000 Aug; 46(2):215-21. PubMed ID: 10933643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions.
    Oteo J; Navarro C; Cercenado E; Delgado-Iribarren A; Wilhelmi I; Orden B; García C; Miguelañez S; Pérez-Vázquez M; García-Cobos S; Aracil B; Bautista V; Campos J
    J Clin Microbiol; 2006 Jul; 44(7):2359-66. PubMed ID: 16825350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
    Tian GB; Huang YM; Fang ZL; Qing Y; Zhang XF; Huang X
    J Antimicrob Chemother; 2014 Aug; 69(8):2081-5. PubMed ID: 24777903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Specific Patterns of Genetic Diversity among IncI1-Iγ and IncK Plasmids Encoding CMY-2 β-Lactamase in Escherichia coli Isolates from Humans, Poultry Meat, Poultry, and Dogs in Denmark.
    Hansen KH; Bortolaia V; Nielsen CA; Nielsen JB; Schønning K; Agersø Y; Guardabassi L
    Appl Environ Microbiol; 2016 Aug; 82(15):4705-14. PubMed ID: 27235431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
    Blahová J; Králiková K; Krcméry V; Schäfer V
    J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of eight different cephalosporins for detection of cephalosporin resistance in Salmonella enterica and Escherichia coli.
    Aarestrup FM; Hasman H; Veldman K; Mevius D
    Microb Drug Resist; 2010 Dec; 16(4):253-61. PubMed ID: 20624078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of efflux to cefuroxime resistance in clinical isolates of Escherichia coli.
    Källman O; Fendukly F; Karlsson I; Kronvall G
    Scand J Infect Dis; 2003; 35(8):464-70. PubMed ID: 14514145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia.
    Alyamani EJ; Khiyami AM; Booq RY; Majrashi MA; Bahwerth FS; Rechkina E
    Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):1. PubMed ID: 28061852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterization of cefotaxime and ciprofloxacin co-resistant Escherichia coli isolates in retail chicken carcasses and Ground Pork, China.
    Xu X; Cui S; Zhang F; Luo Y; Gu Y; Yang B; Li F; Chen Q; Zhou G; Wang Y; Pang L; Lin L
    Microb Drug Resist; 2014 Feb; 20(1):73-81. PubMed ID: 23952362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A; Maharjan S; Gaulton T; Doumith M; Soares NC; Dhanji H; Warner M; Doyle M; Hickey M; Downie G; Bou G; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
    J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.
    Pörnull KJ; Göransson E; Rytting AS; Dornbusch K
    J Antimicrob Chemother; 1993 Oct; 32(4):559-70. PubMed ID: 8288497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
    Briñas L; Moreno MA; Teshager T; Zarazaga M; Sáenz Y; Porrero C; Dominguez L; Torres C
    Microb Drug Resist; 2003; 9(2):201-9. PubMed ID: 12820806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.